Qinfeng Li
Zhejiang Key Laboratory Of Cardiovascular Intervention And Precision Medicine, Sir Run Run Shaw Hospital
Hangzhou, China
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Mitochondrial Tumor Suppressor 1A Attenuates Myocardial Infarction Injury by Maintaining the Coupling Between Mitochondria and Endoplasmic Reticulum.
Journal: Circulation
Published: June 30, 2025
Asb10 accelerates pathological cardiac remodeling by stabilizing HSP70.
Journal: Cell death & disease
Published: July 24, 2024
Cardiomyocyte IL-1R2 protects heart from ischemia/reperfusion injury by attenuating IL-17RA-mediated cardiomyocyte apoptosis.
Journal: Cell death & disease
Published: May 11, 2021
Cardiomyocyte-derived small extracellular vesicles can signal eNOS activation in cardiac microvascular endothelial cells to protect against Ischemia/Reperfusion injury.
Journal: Theranostics
Published: December 17, 2019
Bone marrow mesenchymal stem cell-secreted exosomes carrying microRNA-125b protect against myocardial ischemia reperfusion injury via targeting SIRT7.
Journal: Molecular and cellular biochemistry
Published: September 24, 2019
Inhibition of microRNA-34a mediates protection of thymosin beta 4 in endothelial progenitor cells against advanced glycation endproducts by targeting B-cell lymphoma 2.
Journal: Canadian journal of physiology and pharmacology
Published: August 10, 2019
Chronic activation of hexosamine biosynthesis in the heart triggers pathological cardiac remodeling.
Chronic activation of hexosamine biosynthesis in the heart triggers pathological cardiac remodeling.
Journal: Nature communications
Published: March 11, 2019
Pioglitazone restores the homocysteine‑impaired function of endothelial progenitor cells via the inhibition of the protein kinase C/NADPH oxidase pathway.
Journal: Molecular medicine reports
Published: December 10, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026